The name of this superfamily has been modified since the most recent official CATH+ release (v4_3_0). At the point of the last release, this superfamily was named:
"SH2 domain
".
FunFam 12: Tyrosine-protein phosphatase non-receptor type
Please note: GO annotations are assigned to the full protein sequence rather than individual protein domains. Since a given protein can contain multiple domains, it is possible that some of the annotations below come from additional domains that occur in the same protein, but have been classified elsewhere in CATH.
There are 53 GO terms relating to "molecular function"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Protein binding GO:0005515
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
|
22 |
A0A2R8QL35 (/IPI)
F1N339 (/IPI)
F1N339 (/IPI)
F1QZU5 (/IPI)
P29349 (/IPI)
P29349 (/IPI)
P29350 (/IPI)
P29350 (/IPI)
P29350 (/IPI)
P29351 (/IPI)
(12 more) |
Phosphotyrosine residue binding GO:0001784
Interacting selectively and non-covalently with a phosphorylated tyrosine residue within a protein.
|
14 |
P29349 (/IPI)
P29349 (/IPI)
P29350 (/IPI)
P29350 (/IPI)
P29350 (/IPI)
P29351 (/IPI)
Q06124 (/IPI)
Q06124 (/IPI)
Q06124 (/IPI)
Q06124 (/IPI)
(4 more) |
Protein tyrosine phosphatase activity GO:0004725
Catalysis of the reaction: protein tyrosine phosphate + H2O = protein tyrosine + phosphate.
|
14 |
A0A2R8QL35 (/IDA)
F1QZU5 (/IDA)
P29351 (/IDA)
P35235 (/IDA)
P41499 (/IDA)
Q06124 (/IDA)
Q06124 (/IDA)
Q06124 (/IDA)
Q06124 (/IDA)
Q06124 (/IDA)
(4 more) |
Protein tyrosine phosphatase activity GO:0004725
Catalysis of the reaction: protein tyrosine phosphate + H2O = protein tyrosine + phosphate.
|
13 |
P29350 (/TAS)
P29350 (/TAS)
P29350 (/TAS)
P29351 (/TAS)
P81718 (/TAS)
Q06124 (/TAS)
Q06124 (/TAS)
Q06124 (/TAS)
Q06124 (/TAS)
Q06124 (/TAS)
(3 more) |
Phosphotyrosine residue binding GO:0001784
Interacting selectively and non-covalently with a phosphorylated tyrosine residue within a protein.
|
11 |
P29350 (/IMP)
P29350 (/IMP)
P29350 (/IMP)
Q06124 (/IMP)
Q06124 (/IMP)
Q06124 (/IMP)
Q06124 (/IMP)
Q06124 (/IMP)
Q06124 (/IMP)
Q06124 (/IMP)
(1 more) |
Protein tyrosine phosphatase activity GO:0004725
Catalysis of the reaction: protein tyrosine phosphate + H2O = protein tyrosine + phosphate.
|
11 |
P29350 (/IMP)
P29350 (/IMP)
P29350 (/IMP)
Q06124 (/IMP)
Q06124 (/IMP)
Q06124 (/IMP)
Q06124 (/IMP)
Q06124 (/IMP)
Q06124 (/IMP)
Q06124 (/IMP)
(1 more) |
Phosphoprotein phosphatase activity GO:0004721
Catalysis of the reaction: a phosphoprotein + H2O = a protein + phosphate. Together with protein kinases, these enzymes control the state of phosphorylation of cell proteins and thereby provide an important mechanism for regulating cellular activity.
|
8 | Q06124 (/IDA) Q06124 (/IDA) Q06124 (/IDA) Q06124 (/IDA) Q06124 (/IDA) Q06124 (/IDA) Q06124 (/IDA) Q06124 (/IDA) |
Protein tyrosine phosphatase activity GO:0004725
Catalysis of the reaction: protein tyrosine phosphate + H2O = protein tyrosine + phosphate.
|
8 | Q06124 (/EXP) Q06124 (/EXP) Q06124 (/EXP) Q06124 (/EXP) Q06124 (/EXP) Q06124 (/EXP) Q06124 (/EXP) Q06124 (/EXP) |
Non-membrane spanning protein tyrosine phosphatase activity GO:0004726
Catalysis of the reaction: non-membrane spanning protein tyrosine phosphate + H2O = non-membrane spanning protein tyrosine + phosphate.
|
8 | Q06124 (/IMP) Q06124 (/IMP) Q06124 (/IMP) Q06124 (/IMP) Q06124 (/IMP) Q06124 (/IMP) Q06124 (/IMP) Q06124 (/IMP) |
Non-membrane spanning protein tyrosine phosphatase activity GO:0004726
Catalysis of the reaction: non-membrane spanning protein tyrosine phosphate + H2O = non-membrane spanning protein tyrosine + phosphate.
|
8 | Q06124 (/TAS) Q06124 (/TAS) Q06124 (/TAS) Q06124 (/TAS) Q06124 (/TAS) Q06124 (/TAS) Q06124 (/TAS) Q06124 (/TAS) |
SH3/SH2 adaptor activity GO:0005070
Interacting selectively and non-covalently and simultaneously with one or more signal transduction molecules, usually acting as a scaffold to bring these molecules into close proximity either using their own SH2/SH3 domains (e.g. Grb2) or those of their target molecules (e.g. SAM68).
|
8 | Q06124 (/IPI) Q06124 (/IPI) Q06124 (/IPI) Q06124 (/IPI) Q06124 (/IPI) Q06124 (/IPI) Q06124 (/IPI) Q06124 (/IPI) |
Insulin receptor binding GO:0005158
Interacting selectively and non-covalently with the insulin receptor.
|
8 | Q06124 (/IPI) Q06124 (/IPI) Q06124 (/IPI) Q06124 (/IPI) Q06124 (/IPI) Q06124 (/IPI) Q06124 (/IPI) Q06124 (/IPI) |
Protein kinase binding GO:0019901
Interacting selectively and non-covalently with a protein kinase, any enzyme that catalyzes the transfer of a phosphate group, usually from ATP, to a protein substrate.
|
8 | Q06124 (/ISS) Q06124 (/ISS) Q06124 (/ISS) Q06124 (/ISS) Q06124 (/ISS) Q06124 (/ISS) Q06124 (/ISS) Q06124 (/ISS) |
Phosphatase activity GO:0016791
Catalysis of the hydrolysis of phosphoric monoesters, releasing inorganic phosphate.
|
7 | A0A0R4IH26 (/IDA) A0A2R8QL35 (/IDA) F1QZU5 (/IDA) F1R1Z7 (/IDA) Q7SY37 (/IDA) Q7ZW17 (/IDA) S6CMQ2 (/IDA) |
Protein kinase binding GO:0019901
Interacting selectively and non-covalently with a protein kinase, any enzyme that catalyzes the transfer of a phosphate group, usually from ATP, to a protein substrate.
|
4 | P29350 (/IPI) P29350 (/IPI) P29350 (/IPI) P35235 (/IPI) |
Transmembrane receptor protein tyrosine phosphatase activity GO:0005001
Combining with a signal and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity by catalysis of the reaction: protein tyrosine phosphate + H2O = protein tyrosine + phosphate.
|
3 | P29350 (/IDA) P29350 (/IDA) P29350 (/IDA) |
Cell adhesion molecule binding GO:0050839
Interacting selectively and non-covalently with a cell adhesion molecule.
|
3 | P29351 (/IPI) P35235 (/IPI) P41499 (/IPI) |
Phosphorylation-dependent protein binding GO:0140031
Interacting selectively and non-covalently with a protein upon phosphorylation of the target protein.
|
3 | P29350 (/IPI) P29350 (/IPI) P29350 (/IPI) |
Phosphotyrosine residue binding GO:0001784
Interacting selectively and non-covalently with a phosphorylated tyrosine residue within a protein.
|
2 | P29351 (/ISO) P35235 (/ISO) |
Protein tyrosine phosphatase activity GO:0004725
Catalysis of the reaction: protein tyrosine phosphate + H2O = protein tyrosine + phosphate.
|
2 | P29351 (/ISO) P35235 (/ISO) |
Non-membrane spanning protein tyrosine phosphatase activity GO:0004726
Catalysis of the reaction: non-membrane spanning protein tyrosine phosphate + H2O = non-membrane spanning protein tyrosine + phosphate.
|
2 | P29349 (/IDA) P29349 (/IDA) |
Non-membrane spanning protein tyrosine phosphatase activity GO:0004726
Catalysis of the reaction: non-membrane spanning protein tyrosine phosphate + H2O = non-membrane spanning protein tyrosine + phosphate.
|
2 | P35235 (/ISS) P41499 (/ISS) |
Non-membrane spanning protein tyrosine phosphatase activity GO:0004726
Catalysis of the reaction: non-membrane spanning protein tyrosine phosphate + H2O = non-membrane spanning protein tyrosine + phosphate.
|
2 | P29349 (/NAS) P29349 (/NAS) |
Transmembrane receptor protein tyrosine phosphatase activity GO:0005001
Combining with a signal and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity by catalysis of the reaction: protein tyrosine phosphate + H2O = protein tyrosine + phosphate.
|
2 | P29351 (/ISS) P81718 (/ISS) |
Transmembrane receptor protein tyrosine kinase adaptor activity GO:0005068
The binding activity of a molecule that brings together a transmembrane receptor protein tyrosine kinase and one or more other molecules, permitting them to function in a coordinated way.
|
2 | P29349 (/IPI) P29349 (/IPI) |
Receptor tyrosine kinase binding GO:0030971
Interacting selectively and non-covalently with a receptor that possesses protein tyrosine kinase activity.
|
2 | P35235 (/IPI) P41499 (/IPI) |
Phosphoprotein phosphatase activity GO:0004721
Catalysis of the reaction: a phosphoprotein + H2O = a protein + phosphate. Together with protein kinases, these enzymes control the state of phosphorylation of cell proteins and thereby provide an important mechanism for regulating cellular activity.
|
1 | P35235 (/IMP) |
Phosphoprotein phosphatase activity GO:0004721
Catalysis of the reaction: a phosphoprotein + H2O = a protein + phosphate. Together with protein kinases, these enzymes control the state of phosphorylation of cell proteins and thereby provide an important mechanism for regulating cellular activity.
|
1 | P35235 (/ISO) |
Protein tyrosine phosphatase activity GO:0004725
Catalysis of the reaction: protein tyrosine phosphate + H2O = protein tyrosine + phosphate.
|
1 | Q90687 (/ISS) |
Non-membrane spanning protein tyrosine phosphatase activity GO:0004726
Catalysis of the reaction: non-membrane spanning protein tyrosine phosphate + H2O = non-membrane spanning protein tyrosine + phosphate.
|
1 | P35235 (/ISO) |
Transmembrane receptor protein tyrosine phosphatase activity GO:0005001
Combining with a signal and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity by catalysis of the reaction: protein tyrosine phosphate + H2O = protein tyrosine + phosphate.
|
1 | P29351 (/ISO) |
SH3/SH2 adaptor activity GO:0005070
Interacting selectively and non-covalently and simultaneously with one or more signal transduction molecules, usually acting as a scaffold to bring these molecules into close proximity either using their own SH2/SH3 domains (e.g. Grb2) or those of their target molecules (e.g. SAM68).
|
1 | P35235 (/ISO) |
Insulin receptor binding GO:0005158
Interacting selectively and non-covalently with the insulin receptor.
|
1 | P41499 (/IDA) |
Insulin receptor binding GO:0005158
Interacting selectively and non-covalently with the insulin receptor.
|
1 | P35235 (/ISO) |
SH3 domain binding GO:0017124
Interacting selectively and non-covalently with a SH3 domain (Src homology 3) of a protein, small protein modules containing approximately 50 amino acid residues found in a great variety of intracellular or membrane-associated proteins.
|
1 | P29351 (/IDA) |
Protein kinase binding GO:0019901
Interacting selectively and non-covalently with a protein kinase, any enzyme that catalyzes the transfer of a phosphate group, usually from ATP, to a protein substrate.
|
1 | P29351 (/ISO) |
Protein domain specific binding GO:0019904
Interacting selectively and non-covalently with a specific domain of a protein.
|
1 | P41499 (/IPI) |
Protein domain specific binding GO:0019904
Interacting selectively and non-covalently with a specific domain of a protein.
|
1 | P35235 (/ISO) |
Receptor tyrosine kinase binding GO:0030971
Interacting selectively and non-covalently with a receptor that possesses protein tyrosine kinase activity.
|
1 | P35235 (/ISO) |
D1 dopamine receptor binding GO:0031748
Interacting selectively and non-covalently with a D1 dopamine receptor.
|
1 | P41499 (/IPI) |
D1 dopamine receptor binding GO:0031748
Interacting selectively and non-covalently with a D1 dopamine receptor.
|
1 | P35235 (/ISO) |
SH2 domain binding GO:0042169
Interacting selectively and non-covalently with a SH2 domain (Src homology 2) of a protein, a protein domain of about 100 amino-acid residues and belonging to the alpha + beta domain class.
|
1 | P29351 (/IDA) |
Phospholipase binding GO:0043274
Interacting selectively and non-covalently with any phospholipase, enzymes that catalyze of the hydrolysis of a glycerophospholipid.
|
1 | P41499 (/IDA) |
Phospholipase binding GO:0043274
Interacting selectively and non-covalently with any phospholipase, enzymes that catalyze of the hydrolysis of a glycerophospholipid.
|
1 | P35235 (/ISO) |
Insulin receptor substrate binding GO:0043560
Interacting selectively and non-covalently with any of the insulin receptor substrate (IRS) proteins, adaptor proteins that bind to the transphosphorylated insulin and insulin-like growth factor receptors, are themselves phosphorylated and in turn recruit SH2 domain-containing signaling molecules to form a productive signaling complex.
|
1 | P41499 (/IPI) |
Insulin receptor substrate binding GO:0043560
Interacting selectively and non-covalently with any of the insulin receptor substrate (IRS) proteins, adaptor proteins that bind to the transphosphorylated insulin and insulin-like growth factor receptors, are themselves phosphorylated and in turn recruit SH2 domain-containing signaling molecules to form a productive signaling complex.
|
1 | P35235 (/ISO) |
Natural killer cell lectin-like receptor binding GO:0046703
Interacting selectively and non-covalently with a lectin-like natural killer cell receptor.
|
1 | P81718 (/IPI) |
Natural killer cell lectin-like receptor binding GO:0046703
Interacting selectively and non-covalently with a lectin-like natural killer cell receptor.
|
1 | P29351 (/ISO) |
Cell adhesion molecule binding GO:0050839
Interacting selectively and non-covalently with a cell adhesion molecule.
|
1 | P35235 (/ISO) |
Peptide hormone receptor binding GO:0051428
Interacting selectively and non-covalently with a receptor for peptide hormones.
|
1 | P35235 (/IPI) |
Phosphorylation-dependent protein binding GO:0140031
Interacting selectively and non-covalently with a protein upon phosphorylation of the target protein.
|
1 | P29351 (/ISO) |
Protein tyrosine kinase binding GO:1990782
Interacting selectively and non-covalently with protein tyrosine kinase.
|
1 | P41499 (/IPI) |
Protein tyrosine kinase binding GO:1990782
Interacting selectively and non-covalently with protein tyrosine kinase.
|
1 | P35235 (/ISO) |
There are 169 GO terms relating to "biological process"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Cytokine-mediated signaling pathway GO:0019221
A series of molecular signals initiated by the binding of a cytokine to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
12 |
P29350 (/TAS)
P29350 (/TAS)
P29350 (/TAS)
P29351 (/TAS)
Q06124 (/TAS)
Q06124 (/TAS)
Q06124 (/TAS)
Q06124 (/TAS)
Q06124 (/TAS)
Q06124 (/TAS)
(2 more) |
Heart development GO:0007507
The process whose specific outcome is the progression of the heart over time, from its formation to the mature structure. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood.
|
11 |
A0A2R8QL35 (/IMP)
F1QZU5 (/IMP)
Q06124 (/IMP)
Q06124 (/IMP)
Q06124 (/IMP)
Q06124 (/IMP)
Q06124 (/IMP)
Q06124 (/IMP)
Q06124 (/IMP)
Q06124 (/IMP)
(1 more) |
Platelet activation GO:0030168
A series of progressive, overlapping events triggered by exposure of the platelets to subendothelial tissue. These events include shape change, adhesiveness, aggregation, and release reactions. When carried through to completion, these events lead to the formation of a stable hemostatic plug.
|
11 |
P29350 (/TAS)
P29350 (/TAS)
P29350 (/TAS)
Q06124 (/TAS)
Q06124 (/TAS)
Q06124 (/TAS)
Q06124 (/TAS)
Q06124 (/TAS)
Q06124 (/TAS)
Q06124 (/TAS)
(1 more) |
T cell costimulation GO:0031295
The process of providing, via surface-bound receptor-ligand pairs, a second, antigen-independent, signal in addition to that provided by the T cell receptor to augment T cell activation.
|
11 |
P29350 (/TAS)
P29350 (/TAS)
P29350 (/TAS)
Q06124 (/TAS)
Q06124 (/TAS)
Q06124 (/TAS)
Q06124 (/TAS)
Q06124 (/TAS)
Q06124 (/TAS)
Q06124 (/TAS)
(1 more) |
Peptidyl-tyrosine dephosphorylation GO:0035335
The removal of phosphoric residues from peptidyl-O-phospho-tyrosine to form peptidyl-tyrosine.
|
11 |
P29350 (/IMP)
P29350 (/IMP)
P29350 (/IMP)
Q06124 (/IMP)
Q06124 (/IMP)
Q06124 (/IMP)
Q06124 (/IMP)
Q06124 (/IMP)
Q06124 (/IMP)
Q06124 (/IMP)
(1 more) |
Leukocyte migration GO:0050900
The movement of a leukocyte within or between different tissues and organs of the body.
|
11 |
P29350 (/TAS)
P29350 (/TAS)
P29350 (/TAS)
Q06124 (/TAS)
Q06124 (/TAS)
Q06124 (/TAS)
Q06124 (/TAS)
Q06124 (/TAS)
Q06124 (/TAS)
Q06124 (/TAS)
(1 more) |
Regulation of type I interferon-mediated signaling pathway GO:0060338
Any process that modulates the rate, frequency or extent of a type I interferon-mediated signaling pathway. A type I interferon-mediated signaling pathway is the series of molecular events generated as a consequence of a type I interferon binding to a cell surface receptor.
|
11 |
P29350 (/TAS)
P29350 (/TAS)
P29350 (/TAS)
Q06124 (/TAS)
Q06124 (/TAS)
Q06124 (/TAS)
Q06124 (/TAS)
Q06124 (/TAS)
Q06124 (/TAS)
Q06124 (/TAS)
(1 more) |
Cellular response to cytokine stimulus GO:0071345
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cytokine stimulus.
|
11 |
P29350 (/TAS)
P29350 (/TAS)
P29350 (/TAS)
Q06124 (/TAS)
Q06124 (/TAS)
Q06124 (/TAS)
Q06124 (/TAS)
Q06124 (/TAS)
Q06124 (/TAS)
Q06124 (/TAS)
(1 more) |
Epidermal growth factor receptor signaling pathway GO:0007173
A series of molecular signals initiated by binding of a ligand to the tyrosine kinase receptor EGFR (ERBB1) on the surface of a cell. The pathway ends with regulation of a downstream cellular process, e.g. transcription.
|
8 | Q06124 (/TAS) Q06124 (/TAS) Q06124 (/TAS) Q06124 (/TAS) Q06124 (/TAS) Q06124 (/TAS) Q06124 (/TAS) Q06124 (/TAS) |
Axon guidance GO:0007411
The chemotaxis process that directs the migration of an axon growth cone to a specific target site in response to a combination of attractive and repulsive cues.
|
8 | Q06124 (/TAS) Q06124 (/TAS) Q06124 (/TAS) Q06124 (/TAS) Q06124 (/TAS) Q06124 (/TAS) Q06124 (/TAS) Q06124 (/TAS) |
Brain development GO:0007420
The process whose specific outcome is the progression of the brain over time, from its formation to the mature structure. Brain development begins with patterning events in the neural tube and ends with the mature structure that is the center of thought and emotion. The brain is responsible for the coordination and control of bodily activities and the interpretation of information from the senses (sight, hearing, smell, etc.).
|
8 | Q06124 (/IMP) Q06124 (/IMP) Q06124 (/IMP) Q06124 (/IMP) Q06124 (/IMP) Q06124 (/IMP) Q06124 (/IMP) Q06124 (/IMP) |
Fibroblast growth factor receptor signaling pathway GO:0008543
The series of molecular signals generated as a consequence of a fibroblast growth factor receptor binding to one of its physiological ligands.
|
8 | Q06124 (/TAS) Q06124 (/TAS) Q06124 (/TAS) Q06124 (/TAS) Q06124 (/TAS) Q06124 (/TAS) Q06124 (/TAS) Q06124 (/TAS) |
Positive regulation of interferon-beta production GO:0032728
Any process that activates or increases the frequency, rate, or extent of interferon-beta production.
|
8 | Q06124 (/ISS) Q06124 (/ISS) Q06124 (/ISS) Q06124 (/ISS) Q06124 (/ISS) Q06124 (/ISS) Q06124 (/ISS) Q06124 (/ISS) |
Positive regulation of interleukin-6 production GO:0032755
Any process that activates or increases the frequency, rate, or extent of interleukin-6 production.
|
8 | Q06124 (/ISS) Q06124 (/ISS) Q06124 (/ISS) Q06124 (/ISS) Q06124 (/ISS) Q06124 (/ISS) Q06124 (/ISS) Q06124 (/ISS) |
Positive regulation of tumor necrosis factor production GO:0032760
Any process that activates or increases the frequency, rate, or extent of tumor necrosis factor production.
|
8 | Q06124 (/ISS) Q06124 (/ISS) Q06124 (/ISS) Q06124 (/ISS) Q06124 (/ISS) Q06124 (/ISS) Q06124 (/ISS) Q06124 (/ISS) |
Regulation of cell adhesion mediated by integrin GO:0033628
Any process that modulates the frequency, rate, or extent of cell adhesion mediated by integrin.
|
8 | Q06124 (/IMP) Q06124 (/IMP) Q06124 (/IMP) Q06124 (/IMP) Q06124 (/IMP) Q06124 (/IMP) Q06124 (/IMP) Q06124 (/IMP) |
Peptidyl-tyrosine dephosphorylation GO:0035335
The removal of phosphoric residues from peptidyl-O-phospho-tyrosine to form peptidyl-tyrosine.
|
8 | Q06124 (/IDA) Q06124 (/IDA) Q06124 (/IDA) Q06124 (/IDA) Q06124 (/IDA) Q06124 (/IDA) Q06124 (/IDA) Q06124 (/IDA) |
Atrioventricular canal development GO:0036302
The progression of the atrioventricular canal over time, from its formation to the mature structure. The atrioventricular canal is the part of the heart connecting the atrium to the cardiac ventricle.
|
8 | Q06124 (/IMP) Q06124 (/IMP) Q06124 (/IMP) Q06124 (/IMP) Q06124 (/IMP) Q06124 (/IMP) Q06124 (/IMP) Q06124 (/IMP) |
ERBB signaling pathway GO:0038127
A series of molecular signals initiated by binding of a ligand to a member of the ERBB family of receptor tyrosine kinases on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
8 | Q06124 (/IDA) Q06124 (/IDA) Q06124 (/IDA) Q06124 (/IDA) Q06124 (/IDA) Q06124 (/IDA) Q06124 (/IDA) Q06124 (/IDA) |
Regulation of protein complex assembly GO:0043254
Any process that modulates the frequency, rate or extent of protein complex assembly.
|
8 | Q06124 (/IDA) Q06124 (/IDA) Q06124 (/IDA) Q06124 (/IDA) Q06124 (/IDA) Q06124 (/IDA) Q06124 (/IDA) Q06124 (/IDA) |
Positive regulation of glucose import GO:0046326
Any process that activates or increases the frequency, rate or extent of the import of the hexose monosaccharide glucose into a cell or organelle.
|
8 | Q06124 (/IDA) Q06124 (/IDA) Q06124 (/IDA) Q06124 (/IDA) Q06124 (/IDA) Q06124 (/IDA) Q06124 (/IDA) Q06124 (/IDA) |
Positive regulation of insulin receptor signaling pathway GO:0046628
Any process that increases the frequency, rate or extent of insulin receptor signaling.
|
8 | Q06124 (/IDA) Q06124 (/IDA) Q06124 (/IDA) Q06124 (/IDA) Q06124 (/IDA) Q06124 (/IDA) Q06124 (/IDA) Q06124 (/IDA) |
Ephrin receptor signaling pathway GO:0048013
The series of molecular signals generated as a consequence of an ephrin receptor binding to an ephrin.
|
8 | Q06124 (/IDA) Q06124 (/IDA) Q06124 (/IDA) Q06124 (/IDA) Q06124 (/IDA) Q06124 (/IDA) Q06124 (/IDA) Q06124 (/IDA) |
Genitalia development GO:0048806
The process whose specific outcome is the progression of the genitalia over time, from its formation to the mature structure.
|
8 | Q06124 (/IMP) Q06124 (/IMP) Q06124 (/IMP) Q06124 (/IMP) Q06124 (/IMP) Q06124 (/IMP) Q06124 (/IMP) Q06124 (/IMP) |
Inner ear development GO:0048839
The process whose specific outcome is the progression of the inner ear over time, from its formation to the mature structure.
|
8 | Q06124 (/IMP) Q06124 (/IMP) Q06124 (/IMP) Q06124 (/IMP) Q06124 (/IMP) Q06124 (/IMP) Q06124 (/IMP) Q06124 (/IMP) |
Positive regulation of peptidyl-tyrosine phosphorylation GO:0050731
Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-tyrosine.
|
8 | Q06124 (/IMP) Q06124 (/IMP) Q06124 (/IMP) Q06124 (/IMP) Q06124 (/IMP) Q06124 (/IMP) Q06124 (/IMP) Q06124 (/IMP) |
Positive regulation of protein kinase B signaling GO:0051897
Any process that activates or increases the frequency, rate or extent of protein kinase B signaling, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B.
|
8 | Q06124 (/TAS) Q06124 (/TAS) Q06124 (/TAS) Q06124 (/TAS) Q06124 (/TAS) Q06124 (/TAS) Q06124 (/TAS) Q06124 (/TAS) |
Face morphogenesis GO:0060325
The process in which the anatomical structures of the face are generated and organized. The face is the ventral division of the head.
|
8 | Q06124 (/IMP) Q06124 (/IMP) Q06124 (/IMP) Q06124 (/IMP) Q06124 (/IMP) Q06124 (/IMP) Q06124 (/IMP) Q06124 (/IMP) |
Interleukin-6-mediated signaling pathway GO:0070102
A series of molecular signals initiated by the binding of interleukin-6 to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
8 | Q06124 (/TAS) Q06124 (/TAS) Q06124 (/TAS) Q06124 (/TAS) Q06124 (/TAS) Q06124 (/TAS) Q06124 (/TAS) Q06124 (/TAS) |
Positive regulation of ERK1 and ERK2 cascade GO:0070374
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.
|
8 | Q06124 (/IMP) Q06124 (/IMP) Q06124 (/IMP) Q06124 (/IMP) Q06124 (/IMP) Q06124 (/IMP) Q06124 (/IMP) Q06124 (/IMP) |
Cellular response to epidermal growth factor stimulus GO:0071364
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an epidermal growth factor stimulus.
|
8 | Q06124 (/IMP) Q06124 (/IMP) Q06124 (/IMP) Q06124 (/IMP) Q06124 (/IMP) Q06124 (/IMP) Q06124 (/IMP) Q06124 (/IMP) |
Protein dephosphorylation GO:0006470
The process of removing one or more phosphoric residues from a protein.
|
7 | P29349 (/IDA) P29349 (/IDA) P29350 (/IDA) P29350 (/IDA) P29350 (/IDA) P29351 (/IDA) P41499 (/IDA) |
Embryonic viscerocranium morphogenesis GO:0048703
The process in which the anatomical structures of the viscerocranium are generated and organized during the embryonic phase. The viscerocranium is the part of the skull comprising the facial bones.
|
7 | A0A0R4IH26 (/IGI) A0A2R8QL35 (/IGI) F1QZU5 (/IGI) F1R1Z7 (/IGI) Q7SY37 (/IGI) Q7ZW17 (/IGI) S6CMQ2 (/IGI) |
Innate immune response GO:0045087
Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens.
|
5 | A0A2R8Q2T0 (/IMP) E7F3D4 (/IMP) F8W5L5 (/IMP) F8W5L5 (/IMP) Q803M6 (/IMP) |
Negative regulation of peptidyl-tyrosine phosphorylation GO:0050732
Any process that stops, prevents, or reduces the frequency, rate or extent of the phosphorylation of peptidyl-tyrosine.
|
4 | P29350 (/IMP) P29350 (/IMP) P29350 (/IMP) P29351 (/IMP) |
Heart jogging GO:0003146
The morphogenetic process in which the heart cone is displaced to the left with respect to the vector of the anterior-posterior axis.
|
3 | A0A2R8QL35 (/IMP) F1QZU5 (/IMP) Q7ZW17 (/IMP) |
Apoptotic process GO:0006915
A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died.
|
3 | P29350 (/TAS) P29350 (/TAS) P29350 (/TAS) |
Epidermal growth factor receptor signaling pathway GO:0007173
A series of molecular signals initiated by binding of a ligand to the tyrosine kinase receptor EGFR (ERBB1) on the surface of a cell. The pathway ends with regulation of a downstream cellular process, e.g. transcription.
|
3 | P29349 (/IGI) P29349 (/IGI) P35235 (/IGI) |
G protein-coupled receptor signaling pathway GO:0007186
A series of molecular signals that proceeds with an activated receptor promoting the exchange of GDP for GTP on the alpha-subunit of an associated heterotrimeric G-protein complex. The GTP-bound activated alpha-G-protein then dissociates from the beta- and gamma-subunits to further transmit the signal within the cell. The pathway begins with receptor-ligand interaction, or for basal GPCR signaling the pathway begins with the receptor activating its G protein in the absence of an agonist, and ends with regulation of a downstream cellular process, e.g. transcription. The pathway can start from the plasma membrane, Golgi or nuclear membrane (PMID:24568158 and PMID:16902576).
|
3 | P29350 (/TAS) P29350 (/TAS) P29350 (/TAS) |
Cell population proliferation GO:0008283
The multiplication or reproduction of cells, resulting in the expansion of a cell population.
|
3 | P29350 (/IDA) P29350 (/IDA) P29350 (/IDA) |
Positive regulation of cell population proliferation GO:0008284
Any process that activates or increases the rate or extent of cell proliferation.
|
3 | P29350 (/IMP) P29350 (/IMP) P29350 (/IMP) |
Negative regulation of cell population proliferation GO:0008285
Any process that stops, prevents or reduces the rate or extent of cell proliferation.
|
3 | P29350 (/NAS) P29350 (/NAS) P29350 (/NAS) |
Positive regulation of phosphatidylinositol 3-kinase signaling GO:0014068
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the phosphatidylinositol 3-kinase cascade.
|
3 | P29350 (/IMP) P29350 (/IMP) P29350 (/IMP) |
Peptidyl-tyrosine phosphorylation GO:0018108
The phosphorylation of peptidyl-tyrosine to form peptidyl-O4'-phospho-L-tyrosine.
|
3 | P29350 (/IDA) P29350 (/IDA) P29350 (/IDA) |
Cell differentiation GO:0030154
The process in which relatively unspecialized cells, e.g. embryonic or regenerative cells, acquire specialized structural and/or functional features that characterize the cells, tissues, or organs of the mature organism or some other relatively stable phase of the organism's life history. Differentiation includes the processes involved in commitment of a cell to a specific fate and its subsequent development to the mature state.
|
3 | P29350 (/IDA) P29350 (/IDA) P29350 (/IDA) |
Negative regulation of interleukin-6 production GO:0032715
Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-6 production.
|
3 | P29350 (/ISS) P29350 (/ISS) P29350 (/ISS) |
Negative regulation of tumor necrosis factor production GO:0032720
Any process that stops, prevents, or reduces the frequency, rate, or extent of tumor necrosis factor production.
|
3 | P29350 (/ISS) P29350 (/ISS) P29350 (/ISS) |
Neutrophil degranulation GO:0043312
The regulated exocytosis of secretory granules containing preformed mediators such as proteases, lipases, and inflammatory mediators by a neutrophil.
|
3 | P29350 (/TAS) P29350 (/TAS) P29350 (/TAS) |
Embryonic viscerocranium morphogenesis GO:0048703
The process in which the anatomical structures of the viscerocranium are generated and organized during the embryonic phase. The viscerocranium is the part of the skull comprising the facial bones.
|
3 | A0A2R8QL35 (/IMP) F1QZU5 (/IMP) Q7ZW17 (/IMP) |
Convergent extension involved in gastrulation GO:0060027
The morphogenetic process in which an epithelium narrows along one axis and lengthens in a perpendicular axis usually resulting in the formation of the three primary germ layers, ectoderm, mesoderm and endoderm.
|
3 | A0A2R8QL35 (/IGI) F1QZU5 (/IGI) Q7ZW17 (/IGI) |
Convergent extension involved in gastrulation GO:0060027
The morphogenetic process in which an epithelium narrows along one axis and lengthens in a perpendicular axis usually resulting in the formation of the three primary germ layers, ectoderm, mesoderm and endoderm.
|
3 | A0A2R8QL35 (/IMP) F1QZU5 (/IMP) Q7ZW17 (/IMP) |
Convergent extension involved in axis elongation GO:0060028
The morphogenetic process in which an epithelium narrows along one axis and lengthens in a perpendicular axis contributing to the lengthening of the axis of an organism.
|
3 | A0A2R8QL35 (/IMP) F1QZU5 (/IMP) Q7ZW17 (/IMP) |
Negative regulation of cell death GO:0060548
Any process that decreases the rate or frequency of cell death. Cell death is the specific activation or halting of processes within a cell so that its vital functions markedly cease, rather than simply deteriorating gradually over time, which culminates in cell death.
|
3 | A0A2R8QL35 (/IMP) F1QZU5 (/IMP) Q7ZW17 (/IMP) |
Regulation of ERK1 and ERK2 cascade GO:0070372
Any process that modulates the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.
|
3 | P29350 (/IDA) P29350 (/IDA) P29350 (/IDA) |
Positive regulation of ERK1 and ERK2 cascade GO:0070374
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.
|
3 | P35235 (/ISS) P41499 (/ISS) Q90687 (/ISS) |
Cellular response to epidermal growth factor stimulus GO:0071364
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an epidermal growth factor stimulus.
|
3 | P35235 (/ISS) P41499 (/ISS) Q90687 (/ISS) |
Regulation of G1/S transition of mitotic cell cycle GO:2000045
Any signalling pathway that modulates the activity of a cell cycle cyclin-dependent protein kinase to modulate the switch from G1 phase to S phase of the mitotic cell cycle.
|
3 | P29350 (/IMP) P29350 (/IMP) P29350 (/IMP) |
Mitotic cell cycle GO:0000278
Progression through the phases of the mitotic cell cycle, the most common eukaryotic cell cycle, which canonically comprises four successive phases called G1, S, G2, and M and includes replication of the genome and the subsequent segregation of chromosomes into daughter cells. In some variant cell cycles nuclear replication or nuclear division may not be followed by cell division, or G1 and G2 phases may be absent.
|
2 | P29349 (/IMP) P29349 (/IMP) |
Protein dephosphorylation GO:0006470
The process of removing one or more phosphoric residues from a protein.
|
2 | P29351 (/ISO) P35235 (/ISO) |
Phagocytosis, engulfment GO:0006911
The internalization of bacteria, immune complexes and other particulate matter or of an apoptotic cell by phagocytosis, including the membrane and cytoskeletal processes required, which involves one of three mechanisms: zippering of pseudopods around a target via repeated receptor-ligand interactions, sinking of the target directly into plasma membrane of the phagocytosing cell, or induced uptake via an enhanced membrane ruffling of the phagocytosing cell similar to macropinocytosis.
|
2 | P29349 (/IMP) P29349 (/IMP) |
Epidermal growth factor receptor signaling pathway GO:0007173
A series of molecular signals initiated by binding of a ligand to the tyrosine kinase receptor EGFR (ERBB1) on the surface of a cell. The pathway ends with regulation of a downstream cellular process, e.g. transcription.
|
2 | P29349 (/IMP) P29349 (/IMP) |
Terminal region determination GO:0007362
Specification of the terminal regions (the two non-segmented ends) of the embryo by the gap genes; exemplified in insects by the actions of huckebein and tailless gene products.
|
2 | P29349 (/IMP) P29349 (/IMP) |
Ventral midline development GO:0007418
The process whose specific outcome is the progression of the ventral midline over time, from its formation to the mature structure. In protostomes (such as insects, snails and worms) as well as deuterostomes (vertebrates), the midline is an embryonic region that functions in patterning of the adjacent nervous tissue. The ventral midline in insects is a cell population extending along the ventral surface of the embryo and is the region from which cells detach to form the ventrally located nerve cords. In vertebrates, the midline is originally located dorsally. During development, it folds inwards and becomes the ventral part of the dorsally located neural tube and is then called the ventral midline, or floor plate.
|
2 | P29349 (/IMP) P29349 (/IMP) |
Open tracheal system development GO:0007424
The process whose specific outcome is the progression of an open tracheal system over time, from its formation to the mature structure. An open tracheal system is a respiratory system, a branched network of epithelial tubes that supplies oxygen to target tissues via spiracles. An example of this is found in Drosophila melanogaster.
|
2 | P29349 (/IGI) P29349 (/IGI) |
Epithelial cell migration, open tracheal system GO:0007427
The orderly movement of epithelial cells during development of an open tracheal system. An example of this is found in Drosophila melanogaster.
|
2 | P29349 (/IMP) P29349 (/IMP) |
Imaginal disc development GO:0007444
The process whose specific outcome is the progression of the imaginal disc over time, from its formation to the metamorphosis to form adult structures. Imaginal discs are epithelial infoldings in the larvae of holometabolous insects that develop into adult structures (legs, antennae, wings, etc.).
|
2 | P29349 (/IMP) P29349 (/IMP) |
R7 cell fate commitment GO:0007465
The process in which the R7 photoreceptor commits to its cell fate. The R7 receptor contributes the central part of the rhabdomere in the apical parts of the ommatidium.
|
2 | P29349 (/IGI) P29349 (/IGI) |
Mesoderm development GO:0007498
The process whose specific outcome is the progression of the mesoderm over time, from its formation to the mature structure. The mesoderm is the middle germ layer that develops into muscle, bone, cartilage, blood and connective tissue.
|
2 | P29349 (/IMP) P29349 (/IMP) |
Dorsal/ventral axis specification, ovarian follicular epithelium GO:0008069
Polarization of the ovarian follicle cells along the dorsal/ventral axis. An example of this process is found in Drosophila melanogaster.
|
2 | P29349 (/IMP) P29349 (/IMP) |
Cell population proliferation GO:0008283
The multiplication or reproduction of cells, resulting in the expansion of a cell population.
|
2 | P29351 (/ISS) P81718 (/ISS) |
Torso signaling pathway GO:0008293
A series of molecular signals initiated by the binding of an extracellular ligand to torso (a receptor tyrosine kinase) on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
2 | P29349 (/IGI) P29349 (/IGI) |
Torso signaling pathway GO:0008293
A series of molecular signals initiated by the binding of an extracellular ligand to torso (a receptor tyrosine kinase) on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
2 | P29349 (/IMP) P29349 (/IMP) |
Fibroblast growth factor receptor signaling pathway GO:0008543
The series of molecular signals generated as a consequence of a fibroblast growth factor receptor binding to one of its physiological ligands.
|
2 | P29349 (/IDA) P29349 (/IDA) |
Fibroblast growth factor receptor signaling pathway GO:0008543
The series of molecular signals generated as a consequence of a fibroblast growth factor receptor binding to one of its physiological ligands.
|
2 | P29349 (/IMP) P29349 (/IMP) |
Dephosphorylation GO:0016311
The process of removing one or more phosphoric (ester or anhydride) residues from a molecule.
|
2 | P29349 (/IMP) P29349 (/IMP) |
Cell differentiation GO:0030154
The process in which relatively unspecialized cells, e.g. embryonic or regenerative cells, acquire specialized structural and/or functional features that characterize the cells, tissues, or organs of the mature organism or some other relatively stable phase of the organism's life history. Differentiation includes the processes involved in commitment of a cell to a specific fate and its subsequent development to the mature state.
|
2 | P29351 (/ISS) P81718 (/ISS) |
Platelet formation GO:0030220
The process in which platelets bud from long processes extended by megakaryocytes.
|
2 | P29351 (/IGI) P35235 (/IGI) |
Abortive mitotic cell cycle GO:0033277
A cell cycle in which mitosis is begun and progresses normally through the end of anaphase, but not completed, resulting in a cell with increased ploidy.
|
2 | P29351 (/IMP) P35235 (/IMP) |
Regulation of cell adhesion mediated by integrin GO:0033628
Any process that modulates the frequency, rate, or extent of cell adhesion mediated by integrin.
|
2 | P35235 (/ISS) P41499 (/ISS) |
Peptidyl-tyrosine dephosphorylation GO:0035335
The removal of phosphoric residues from peptidyl-O-phospho-tyrosine to form peptidyl-tyrosine.
|
2 | P29351 (/ISO) P35235 (/ISO) |
Peptidyl-tyrosine dephosphorylation GO:0035335
The removal of phosphoric residues from peptidyl-O-phospho-tyrosine to form peptidyl-tyrosine.
|
2 | P35235 (/ISS) P41499 (/ISS) |
Megakaryocyte development GO:0035855
The process whose specific outcome is the progression of a megakaryocyte cell over time, from its formation to the mature structure. Megakaryocyte development does not include the steps involved in committing a cell to a megakaryocyte fate. A megakaryocyte is a giant cell 50 to 100 micron in diameter, with a greatly lobulated nucleus, found in the bone marrow.
|
2 | P29351 (/IMP) P35235 (/IMP) |
Photoreceptor cell development GO:0042461
Development of a photoreceptor, a cell that responds to incident electromagnetic radiation, particularly visible light.
|
2 | P29349 (/IMP) P29349 (/IMP) |
Negative regulation of apoptotic process GO:0043066
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
|
2 | P29349 (/IMP) P29349 (/IMP) |
Regulation of compound eye photoreceptor development GO:0045314
Any process that modulates the frequency, rate or extent of compound eye photoreceptor development.
|
2 | P29349 (/IMP) P29349 (/IMP) |
Sevenless signaling pathway GO:0045500
A series of molecular signals initiated by the binding of an extracellular ligand to sevenless (sev; a receptor tyrosine kinase) on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
2 | P29349 (/IGI) P29349 (/IGI) |
Ephrin receptor signaling pathway GO:0048013
The series of molecular signals generated as a consequence of an ephrin receptor binding to an ephrin.
|
2 | P35235 (/ISS) P41499 (/ISS) |
Regulation of ERK1 and ERK2 cascade GO:0070372
Any process that modulates the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.
|
2 | P29351 (/ISS) P81718 (/ISS) |
DNA damage checkpoint GO:0000077
A cell cycle checkpoint that regulates progression through the cell cycle in response to DNA damage. A DNA damage checkpoint may blocks cell cycle progression (in G1, G2 or metaphase) or slow the rate at which S phase proceeds.
|
1 | P35235 (/IMP) |
Activation of MAPK activity GO:0000187
The initiation of the activity of the inactive enzyme MAP kinase (MAPK).
|
1 | P35235 (/IMP) |
Hematopoietic progenitor cell differentiation GO:0002244
The process in which precursor cell type acquires the specialized features of a hematopoietic progenitor cell, a class of cell types including myeloid progenitor cells and lymphoid progenitor cells.
|
1 | P29351 (/IMP) |
Negative regulation of humoral immune response mediated by circulating immunoglobulin GO:0002924
Any process that stops, prevents, or reduces the frequency, rate, or extent of a humoral immune response mediated by circulating immunoglobulin.
|
1 | P29351 (/IMP) |
Protein dephosphorylation GO:0006470
The process of removing one or more phosphoric residues from a protein.
|
1 | P29351 (/IMP) |
Protein dephosphorylation GO:0006470
The process of removing one or more phosphoric residues from a protein.
|
1 | P81718 (/ISS) |
Protein dephosphorylation GO:0006470
The process of removing one or more phosphoric residues from a protein.
|
1 | P81718 (/TAS) |
Lipid metabolic process GO:0006629
The chemical reactions and pathways involving lipids, compounds soluble in an organic solvent but not, or sparingly, in an aqueous solvent. Includes fatty acids; neutral fats, other fatty-acid esters, and soaps; long-chain (fatty) alcohols and waxes; sphingoids and other long-chain bases; glycolipids, phospholipids and sphingolipids; and carotenes, polyprenols, sterols, terpenes and other isoprenoids.
|
1 | P35235 (/IMP) |
Triglyceride metabolic process GO:0006641
The chemical reactions and pathways involving triglyceride, any triester of glycerol. The three fatty acid residues may all be the same or differ in any permutation. Triglycerides are important components of plant oils, animal fats and animal plasma lipoproteins.
|
1 | P35235 (/IMP) |
Integrin-mediated signaling pathway GO:0007229
A series of molecular signals initiated by the binding of extracellular ligand to an integrin on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
1 | P35235 (/IMP) |
Terminal region determination GO:0007362
Specification of the terminal regions (the two non-segmented ends) of the embryo by the gap genes; exemplified in insects by the actions of huckebein and tailless gene products.
|
1 | Q24708 (/ISS) |
Axonogenesis GO:0007409
De novo generation of a long process of a neuron, including the terminal branched region. Refers to the morphogenesis or creation of shape or form of the developing axon, which carries efferent (outgoing) action potentials from the cell body towards target cells.
|
1 | P35235 (/IMP) |
Brain development GO:0007420
The process whose specific outcome is the progression of the brain over time, from its formation to the mature structure. Brain development begins with patterning events in the neural tube and ends with the mature structure that is the center of thought and emotion. The brain is responsible for the coordination and control of bodily activities and the interpretation of information from the senses (sight, hearing, smell, etc.).
|
1 | P35235 (/ISO) |
Heart development GO:0007507
The process whose specific outcome is the progression of the heart over time, from its formation to the mature structure. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood.
|
1 | P35235 (/ISO) |
Cell population proliferation GO:0008283
The multiplication or reproduction of cells, resulting in the expansion of a cell population.
|
1 | P29351 (/ISO) |
Positive regulation of cell population proliferation GO:0008284
Any process that activates or increases the rate or extent of cell proliferation.
|
1 | P29351 (/ISO) |
Torso signaling pathway GO:0008293
A series of molecular signals initiated by the binding of an extracellular ligand to torso (a receptor tyrosine kinase) on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
1 | Q24708 (/ISS) |
Response to wounding GO:0009611
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating damage to the organism.
|
1 | P81718 (/IEP) |
Hormone-mediated signaling pathway GO:0009755
A series of molecular signals mediated by the detection of a hormone.
|
1 | P35235 (/IDA) |
Positive regulation of signal transduction GO:0009967
Any process that activates or increases the frequency, rate or extent of signal transduction.
|
1 | P35235 (/IMP) |
Positive regulation of phosphatidylinositol 3-kinase signaling GO:0014068
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the phosphatidylinositol 3-kinase cascade.
|
1 | P29351 (/ISO) |
Peptidyl-tyrosine phosphorylation GO:0018108
The phosphorylation of peptidyl-tyrosine to form peptidyl-O4'-phospho-L-tyrosine.
|
1 | P29351 (/ISO) |
Cerebellar cortex formation GO:0021697
The process that gives rise to the cerebellar cortex. This process pertains to the initial formation of a structure from unspecified parts. The cerebellar cortex is a thin mantle of gray matter that covers the surface of each cerebral hemisphere. It has a characteristic morphology with convolutions (gyri) and crevices (sulci) that have specific functions. Six layers of nerve cells and the nerve pathways that connect them comprise the cerebellar cortex. Together, these regions are responsible for the processes of conscious thought, perception, emotion and memory as well as advanced motor function.
|
1 | P35235 (/IGI) |
Cerebellar cortex formation GO:0021697
The process that gives rise to the cerebellar cortex. This process pertains to the initial formation of a structure from unspecified parts. The cerebellar cortex is a thin mantle of gray matter that covers the surface of each cerebral hemisphere. It has a characteristic morphology with convolutions (gyri) and crevices (sulci) that have specific functions. Six layers of nerve cells and the nerve pathways that connect them comprise the cerebellar cortex. Together, these regions are responsible for the processes of conscious thought, perception, emotion and memory as well as advanced motor function.
|
1 | P35235 (/IMP) |
Cell differentiation GO:0030154
The process in which relatively unspecialized cells, e.g. embryonic or regenerative cells, acquire specialized structural and/or functional features that characterize the cells, tissues, or organs of the mature organism or some other relatively stable phase of the organism's life history. Differentiation includes the processes involved in commitment of a cell to a specific fate and its subsequent development to the mature state.
|
1 | P29351 (/ISO) |
Microvillus organization GO:0032528
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a microvillus, a thin cylindrical membrane-covered projection on the surface of a cell.
|
1 | P35235 (/IMP) |
Negative regulation of interleukin-6 production GO:0032715
Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-6 production.
|
1 | P29351 (/IGI) |
Negative regulation of tumor necrosis factor production GO:0032720
Any process that stops, prevents, or reduces the frequency, rate, or extent of tumor necrosis factor production.
|
1 | P29351 (/IGI) |
Positive regulation of interferon-beta production GO:0032728
Any process that activates or increases the frequency, rate, or extent of interferon-beta production.
|
1 | P35235 (/IMP) |
Positive regulation of interleukin-6 production GO:0032755
Any process that activates or increases the frequency, rate, or extent of interleukin-6 production.
|
1 | P35235 (/IGI) |
Positive regulation of tumor necrosis factor production GO:0032760
Any process that activates or increases the frequency, rate, or extent of tumor necrosis factor production.
|
1 | P35235 (/IGI) |
Regulation of cell adhesion mediated by integrin GO:0033628
Any process that modulates the frequency, rate, or extent of cell adhesion mediated by integrin.
|
1 | P35235 (/ISO) |
Negative regulation of cell adhesion mediated by integrin GO:0033629
Any process that stops, prevents, or reduces the frequency, rate, or extent of cell adhesion mediated by integrin.
|
1 | P35235 (/IMP) |
Positive regulation of cell adhesion mediated by integrin GO:0033630
Any process that activates or increases the frequency, rate, or extent of cell adhesion mediated by integrin.
|
1 | P29351 (/IMP) |
Multicellular organism growth GO:0035264
The increase in size or mass of an entire multicellular organism, as opposed to cell growth.
|
1 | P35235 (/IMP) |
Organ growth GO:0035265
The increase in size or mass of an organ. Organs are commonly observed as visibly distinct structures, but may also exist as loosely associated clusters of cells that function together as to perform a specific function.
|
1 | P35235 (/IMP) |
Intracellular signal transduction GO:0035556
The process in which a signal is passed on to downstream components within the cell, which become activated themselves to further propagate the signal and finally trigger a change in the function or state of the cell.
|
1 | P29351 (/IDA) |
Atrioventricular canal development GO:0036302
The progression of the atrioventricular canal over time, from its formation to the mature structure. The atrioventricular canal is the part of the heart connecting the atrium to the cardiac ventricle.
|
1 | P35235 (/ISO) |
ERBB signaling pathway GO:0038127
A series of molecular signals initiated by binding of a ligand to a member of the ERBB family of receptor tyrosine kinases on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
1 | P35235 (/ISO) |
Negative regulation of T cell proliferation GO:0042130
Any process that stops, prevents or reduces the rate or extent of T cell proliferation.
|
1 | P29351 (/IMP) |
Natural killer cell mediated cytotoxicity GO:0042267
The directed killing of a target cell by a natural killer cell through the release of granules containing cytotoxic mediators or through the engagement of death receptors.
|
1 | P29351 (/IMP) |
Hormone metabolic process GO:0042445
The chemical reactions and pathways involving any hormone, naturally occurring substances secreted by specialized cells that affects the metabolism or behavior of other cells possessing functional receptors for the hormone.
|
1 | P35235 (/IMP) |
Glucose homeostasis GO:0042593
Any process involved in the maintenance of an internal steady state of glucose within an organism or cell.
|
1 | P35235 (/IMP) |
Regulation of protein complex assembly GO:0043254
Any process that modulates the frequency, rate or extent of protein complex assembly.
|
1 | P35235 (/ISO) |
Negative regulation of MAP kinase activity GO:0043407
Any process that stops, prevents, or reduces the frequency, rate or extent of MAP kinase activity.
|
1 | P29351 (/IMP) |
Negative regulation of MAPK cascade GO:0043409
Any process that stops, prevents, or reduces the frequency, rate or extent of signal transduction mediated by the MAPKKK cascade.
|
1 | P29351 (/IMP) |
Regulation of B cell differentiation GO:0045577
Any process that modulates the frequency, rate or extent of B cell differentiation.
|
1 | P29351 (/IMP) |
Positive regulation of mitotic cell cycle GO:0045931
Any process that activates or increases the rate or extent of progression through the mitotic cell cycle.
|
1 | P35235 (/IGI) |
Positive regulation of glucose import GO:0046326
Any process that activates or increases the frequency, rate or extent of the import of the hexose monosaccharide glucose into a cell or organelle.
|
1 | P35235 (/ISO) |
Positive regulation of insulin receptor signaling pathway GO:0046628
Any process that increases the frequency, rate or extent of insulin receptor signaling.
|
1 | P35235 (/ISO) |
Negative regulation of insulin secretion GO:0046676
Any process that stops, prevents, or reduces the frequency, rate or extent of the regulated release of insulin.
|
1 | P35235 (/IMP) |
Regulation of protein export from nucleus GO:0046825
Any process that modulates the frequency, rate or extent of the directed movement of proteins from the nucleus to the cytoplasm.
|
1 | P35235 (/IMP) |
Positive regulation of hormone secretion GO:0046887
Any process that activates or increases the frequency, rate or extent of the regulated release of a hormone from a cell.
|
1 | P35235 (/IMP) |
Negative regulation of hormone secretion GO:0046888
Any process that stops, prevents, or reduces the frequency, rate or extent of the regulated release of a hormone from a cell.
|
1 | P35235 (/IMP) |
Platelet-derived growth factor receptor signaling pathway GO:0048008
The series of molecular signals generated as a consequence of a platelet-derived growth factor receptor binding to one of its physiological ligands.
|
1 | P35235 (/IGI) |
Neurotrophin TRK receptor signaling pathway GO:0048011
A series of molecular signals initiated by the binding of a neurotrophin to a receptor on the surface of the target cell where the receptor possesses tyrosine kinase activity, and ending with regulation of a downstream cellular process, e.g. transcription.
|
1 | P35235 (/IMP) |
Ephrin receptor signaling pathway GO:0048013
The series of molecular signals generated as a consequence of an ephrin receptor binding to an ephrin.
|
1 | P35235 (/ISO) |
Multicellular organismal reproductive process GO:0048609
The process, occurring above the cellular level, that is pertinent to the reproductive function of a multicellular organism. This includes the integrated processes at the level of tissues and organs.
|
1 | P35235 (/IMP) |
Genitalia development GO:0048806
The process whose specific outcome is the progression of the genitalia over time, from its formation to the mature structure.
|
1 | P35235 (/ISO) |
Inner ear development GO:0048839
The process whose specific outcome is the progression of the inner ear over time, from its formation to the mature structure.
|
1 | P35235 (/ISO) |
Homeostasis of number of cells within a tissue GO:0048873
Any biological process involved in the maintenance of the steady-state number of cells within a population of cells in a tissue.
|
1 | P35235 (/IGI) |
Homeostasis of number of cells within a tissue GO:0048873
Any biological process involved in the maintenance of the steady-state number of cells within a population of cells in a tissue.
|
1 | P35235 (/IMP) |
Negative regulation of peptidyl-tyrosine phosphorylation GO:0050732
Any process that stops, prevents, or reduces the frequency, rate or extent of the phosphorylation of peptidyl-tyrosine.
|
1 | P29351 (/ISO) |
B cell receptor signaling pathway GO:0050853
A series of molecular signals initiated by the cross-linking of an antigen receptor on a B cell.
|
1 | P29351 (/IGI) |
B cell receptor signaling pathway GO:0050853
A series of molecular signals initiated by the cross-linking of an antigen receptor on a B cell.
|
1 | P29351 (/IMP) |
Negative regulation of T cell receptor signaling pathway GO:0050860
Any process that stops, prevents, or reduces the frequency, rate or extent of signaling pathways initiated by the cross-linking of an antigen receptor on a T cell.
|
1 | P29351 (/IMP) |
Regulation of release of sequestered calcium ion into cytosol GO:0051279
Any process that modulates the frequency, rate or extent of the release into the cytosolic compartment of calcium ions sequestered in the endoplasmic reticulum or mitochondria.
|
1 | P29351 (/IGI) |
Negative regulation of cortisol secretion GO:0051463
Any process that stops, prevents, or reduces the frequency, rate or extent of the regulated release of cortisol from a cell.
|
1 | P35235 (/IMP) |
Bergmann glial cell differentiation GO:0060020
The process in which neuroepithelial cells of the neural tube give rise to Brgmann glial cells, specialized bipotential progenitors cells of the cerebellum. Differentiation includes the processes involved in commitment of a cell to a specific fate.
|
1 | P35235 (/IGI) |
Bergmann glial cell differentiation GO:0060020
The process in which neuroepithelial cells of the neural tube give rise to Brgmann glial cells, specialized bipotential progenitors cells of the cerebellum. Differentiation includes the processes involved in commitment of a cell to a specific fate.
|
1 | P35235 (/IMP) |
Negative regulation of growth hormone secretion GO:0060125
Any process that decreases or stops the frequency, rate or extent of the regulated release of growth hormone from a cell.
|
1 | P35235 (/IMP) |
Face morphogenesis GO:0060325
The process in which the anatomical structures of the face are generated and organized. The face is the ventral division of the head.
|
1 | P35235 (/ISO) |
Intestinal epithelial cell migration GO:0061582
The orderly movement of an intestinal epithelial cell from one site to another, often during the development of a multicellular organism.
|
1 | P35235 (/IMP) |
Regulation of ERK1 and ERK2 cascade GO:0070372
Any process that modulates the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.
|
1 | P29351 (/ISO) |
Positive regulation of ERK1 and ERK2 cascade GO:0070374
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.
|
1 | P35235 (/IGI) |
Positive regulation of ERK1 and ERK2 cascade GO:0070374
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.
|
1 | P35235 (/ISO) |
Platelet aggregation GO:0070527
The adhesion of one platelet to one or more other platelets via adhesion molecules.
|
1 | P29351 (/IMP) |
Cellular response to mechanical stimulus GO:0071260
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mechanical stimulus.
|
1 | P41499 (/IPI) |
Cellular response to mechanical stimulus GO:0071260
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mechanical stimulus.
|
1 | P35235 (/ISO) |
Cellular response to epidermal growth factor stimulus GO:0071364
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an epidermal growth factor stimulus.
|
1 | P35235 (/ISO) |
Regulation of G1/S transition of mitotic cell cycle GO:2000045
Any signalling pathway that modulates the activity of a cell cycle cyclin-dependent protein kinase to modulate the switch from G1 phase to S phase of the mitotic cell cycle.
|
1 | P29351 (/ISO) |
There are 26 GO terms relating to "cellular component"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Cytosol GO:0005829
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
|
14 |
P29350 (/TAS)
P29350 (/TAS)
P29350 (/TAS)
P29351 (/TAS)
P35235 (/TAS)
P41499 (/TAS)
Q06124 (/TAS)
Q06124 (/TAS)
Q06124 (/TAS)
Q06124 (/TAS)
(4 more) |
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
|
12 |
P29350 (/IDA)
P29350 (/IDA)
P29350 (/IDA)
Q06124 (/IDA)
Q06124 (/IDA)
Q06124 (/IDA)
Q06124 (/IDA)
Q06124 (/IDA)
Q06124 (/IDA)
Q06124 (/IDA)
(2 more) |
Nucleoplasm GO:0005654
That part of the nuclear content other than the chromosomes or the nucleolus.
|
11 |
P29350 (/TAS)
P29350 (/TAS)
P29350 (/TAS)
Q06124 (/TAS)
Q06124 (/TAS)
Q06124 (/TAS)
Q06124 (/TAS)
Q06124 (/TAS)
Q06124 (/TAS)
Q06124 (/TAS)
(1 more) |
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
11 |
P29350 (/IDA)
P29350 (/IDA)
P29350 (/IDA)
Q06124 (/IDA)
Q06124 (/IDA)
Q06124 (/IDA)
Q06124 (/IDA)
Q06124 (/IDA)
Q06124 (/IDA)
Q06124 (/IDA)
(1 more) |
Protein-containing complex GO:0032991
A stable assembly of two or more macromolecules, i.e. proteins, nucleic acids, carbohydrates or lipids, in which at least one component is a protein and the constituent parts function together.
|
11 |
P29350 (/IMP)
P29350 (/IMP)
P29350 (/IMP)
Q06124 (/IMP)
Q06124 (/IMP)
Q06124 (/IMP)
Q06124 (/IMP)
Q06124 (/IMP)
Q06124 (/IMP)
Q06124 (/IMP)
(1 more) |
Nucleolus GO:0005730
A small, dense body one or more of which are present in the nucleus of eukaryotic cells. It is rich in RNA and protein, is not bounded by a limiting membrane, and is not seen during mitosis. Its prime function is the transcription of the nucleolar DNA into 45S ribosomal-precursor RNA, the processing of this RNA into 5.8S, 18S, and 28S components of ribosomal RNA, and the association of these components with 5S RNA and proteins synthesized outside the nucleolus. This association results in the formation of ribonucleoprotein precursors; these pass into the cytoplasm and mature into the 40S and 60S subunits of the ribosome.
|
4 | P29350 (/IDA) P29350 (/IDA) P29350 (/IDA) Q53XS4 (/IDA) |
Extracellular region GO:0005576
The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
|
3 | P29350 (/TAS) P29350 (/TAS) P29350 (/TAS) |
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
|
3 | P35235 (/ISS) P41499 (/ISS) Q90687 (/ISS) |
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
3 | P35235 (/ISS) Q24708 (/ISS) Q90687 (/ISS) |
Membrane GO:0016020
A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
|
3 | P29350 (/TAS) P29350 (/TAS) P29350 (/TAS) |
Specific granule lumen GO:0035580
The volume enclosed by the membrane of a specific granule, a granule with a membranous, tubular internal structure, found primarily in mature neutrophil cells. Most are released into the extracellular fluid. Specific granules contain lactoferrin, lysozyme, vitamin B12 binding protein and elastase.
|
3 | P29350 (/TAS) P29350 (/TAS) P29350 (/TAS) |
Extracellular exosome GO:0070062
A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
|
3 | P29350 (/HDA) P29350 (/HDA) P29350 (/HDA) |
Tertiary granule lumen GO:1904724
Any membrane-enclosed lumen that is part of a tertiary granule.
|
3 | P29350 (/TAS) P29350 (/TAS) P29350 (/TAS) |
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
|
2 | P29351 (/ISO) P35235 (/ISO) |
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
2 | P29351 (/ISO) P35235 (/ISO) |
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
2 | P29349 (/NAS) P29349 (/NAS) |
Protein-containing complex GO:0032991
A stable assembly of two or more macromolecules, i.e. proteins, nucleic acids, carbohydrates or lipids, in which at least one component is a protein and the constituent parts function together.
|
2 | P29351 (/ISO) P35235 (/ISO) |
Nucleolus GO:0005730
A small, dense body one or more of which are present in the nucleus of eukaryotic cells. It is rich in RNA and protein, is not bounded by a limiting membrane, and is not seen during mitosis. Its prime function is the transcription of the nucleolar DNA into 45S ribosomal-precursor RNA, the processing of this RNA into 5.8S, 18S, and 28S components of ribosomal RNA, and the association of these components with 5S RNA and proteins synthesized outside the nucleolus. This association results in the formation of ribonucleoprotein precursors; these pass into the cytoplasm and mature into the 40S and 60S subunits of the ribosome.
|
1 | P29351 (/ISO) |
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
1 | P29351 (/TAS) |
Mitochondrion GO:0005739
A semiautonomous, self replicating organelle that occurs in varying numbers, shapes, and sizes in the cytoplasm of virtually all eukaryotic cells. It is notably the site of tissue respiration.
|
1 | P41499 (/IDA) |
Mitochondrion GO:0005739
A semiautonomous, self replicating organelle that occurs in varying numbers, shapes, and sizes in the cytoplasm of virtually all eukaryotic cells. It is notably the site of tissue respiration.
|
1 | P35235 (/ISO) |
Cytosol GO:0005829
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
|
1 | P41499 (/IDA) |
Cytosol GO:0005829
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
|
1 | P35235 (/ISO) |
Cell-cell junction GO:0005911
A cell junction that forms a connection between two or more cells in a multicellular organism; excludes direct cytoplasmic junctions such as ring canals.
|
1 | P29351 (/IDA) |
Protein-containing complex GO:0032991
A stable assembly of two or more macromolecules, i.e. proteins, nucleic acids, carbohydrates or lipids, in which at least one component is a protein and the constituent parts function together.
|
1 | P41499 (/IDA) |
Alpha-beta T cell receptor complex GO:0042105
A T cell receptor complex in which the TCR heterodimer comprises alpha and beta chains, associated with the CD3 complex; recognizes a complex consisting of an antigen-derived peptide bound to a class I or class II MHC protein.
|
1 | P29351 (/IDA) |